These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30569132)

  • 21. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity.
    Liu X; Wang B; Sun Y; Jia Y; Xu Z
    Cell Cycle; 2019 Nov; 18(22):3147-3159. PubMed ID: 31564208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
    Pan X; Lv Y
    Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
    Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase.
    Zhang H; Wang X; Xu K; Wang Y; Wang Y; Liu X; Zhang X; Wang L; Li X
    Biochem Biophys Res Commun; 2015 Feb; 457(4):700-5. PubMed ID: 25619134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effects On Retinal Neovascularization by Ranibizumab and sTie2-Fc in An Oxygen-Induced Retinopathy Mouse Model.
    Jiang C; Ruan L; Zhang J; Huang X
    Curr Eye Res; 2018 Sep; 43(9):1190-1198. PubMed ID: 29857790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.
    Wu YC; Chang CY; Kao A; Hsi B; Lee SH; Chen YH; Wang IJ
    PLoS One; 2015; 10(5):e0126750. PubMed ID: 25978439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin promotes retinal angiogenesis in a mouse model.
    Wen CT; He T; Xing YQ
    Mol Med Rep; 2014 Dec; 10(6):2979-84. PubMed ID: 25269825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
    Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
    Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.
    Bartoli M; Al-Shabrawey M; Labazi M; Behzadian MA; Istanboli M; El-Remessy AB; Caldwell RW; Marcus DM; Caldwell RB
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4934-40. PubMed ID: 19098312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.
    Di Y; Zhang Y; Nie Q; Chen X
    Int J Mol Med; 2015 Dec; 36(6):1507-18. PubMed ID: 26459773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7, 8-Dihydroxyflavone, a TrkB receptor agonist, provides minimal protection against retinal vascular damage during oxygen-induced ischemic retinopathy.
    Zaitoun IS; Song YS; Suscha A; El Ragaby M; Sorenson CM; Sheibani N
    PLoS One; 2021; 16(12):e0260793. PubMed ID: 34855884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.
    Hu Y; Wei T; Gao S; Cheng Q
    Inflamm Res; 2019 Nov; 68(11):945-955. PubMed ID: 31444514
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Guo Y; Du F; Tan YL; Luo J; Xiong D; Song WT
    Biochem Cell Biol; 2021 Aug; 99(4):414-423. PubMed ID: 34319836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of Nox2 NADPH oxidase in retinal neovascularization.
    Chan EC; van Wijngaarden P; Liu GS; Jiang F; Peshavariya H; Dusting GJ
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7061-7. PubMed ID: 24106122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.
    Talia DM; Deliyanti D; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1186-96. PubMed ID: 27055905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.